X0708
D
LIVE
0001662774
Quince Therapeutics, Inc.
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
415-910-5717
CALIFORNIA
None
Cortexyme, Inc.
Corporation
true
Dirk
Thye
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Brigette
Roberts
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Charles
Ryan
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Brendan
Hannah
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
David
Lamond
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Director
Christopher
Senner
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Director
June
Bray
611 Gateway Blvd., Suite 273
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2026-05-18
true
true
true
true
false
0
LifeSci Capital
000168404
None
None
1700 Broadway, 40th Floor
New York
NY
NEW YORK
10019
All States
186422679
114720542
71702137
Offering amount includes (a) gross proceeds from sale of shares of preferred stock and warrants and (b) an aggregate gross proceeds that may be received in the future upon the cash exercise in full of the warrants.
false
27
7861000
0
0
false
Quince Therapeutics, Inc.
/s/ Dirk Thye
Dirk Thye
Chief Executive Officer
2026-06-11